Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
NGM BIOPHARMACEUTICALS INC (NGM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
15 Nov 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
134,180
+24%
26,811
$0.68
$18,332.35
BUY
15 Nov 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
949,862
+2%
22,631
$0.69
$15,506.86
BUY
15 Nov 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
949,862
+2%
22,631
$0.69
$15,506.86
BUY
15 Nov 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
949,862
+2%
22,631
$0.69
$15,506.86
BUY
30 Jan 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
927,231
+24%
184,272
$5.00
$921,109.56
BUY
30 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
927,231
+24%
184,272
$5.00
$921,109.56
BUY
30 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
927,231
+24%
184,272
$5.00
$921,109.56
BUY
30 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
927,231
+24%
184,272
$5.00
$921,109.56
BUY
23 Jan 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
742,959
+1%
9,900
$5.00
$49,494.06
BUY
23 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
742,959
+1%
9,900
$5.00
$49,494.06
BUY
23 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
742,959
+1%
9,900
$5.00
$49,494.06
BUY
23 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
742,959
+1%
9,900
$5.00
$49,494.06
BUY
19 Jan 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
733,059
+5%
38,139
$5.00
$190,602.67
BUY
19 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
733,059
+5%
38,139
$5.00
$190,602.67
BUY
19 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
733,059
+5%
38,139
$5.00
$190,602.67
BUY
19 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
733,059
+5%
38,139
$5.00
$190,602.67
SELL
17 Jan 2023
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
908,893
-8%
85,082
$5.15
$438,308.40
BUY
12 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
694,920
+0%
5,378
$4.95
$26,602.81
BUY
12 Jan 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
694,920
+0%
5,378
$4.95
$26,602.81
BUY
12 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
694,920
+0%
5,378
$4.95
$26,602.81
BUY
12 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
694,920
+0%
5,378
$4.95
$26,602.81
BUY
10 Jan 2023
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
689,542
+81%
309,070
$4.79
$1,479,359.00
BUY
10 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
689,542
+81%
309,070
$4.79
$1,479,359.00
BUY
10 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
689,542
+81%
309,070
$4.79
$1,479,359.00
BUY
10 Jan 2023
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
689,542
+81%
309,070
$4.79
$1,479,359.00
BUY
12 Dec 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
380,472
+0%
300
$4.98
$1,493.01
BUY
12 Dec 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
380,472
+0%
300
$4.98
$1,493.01
BUY
12 Dec 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
380,472
+0%
300
$4.98
$1,493.01
BUY
12 Dec 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
380,472
+0%
300
$4.98
$1,493.01
BUY
3 Nov 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
339,845
+69%
139,148
$4.92
$684,426.75
BUY
3 Nov 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
339,845
+69%
139,148
$4.92
$684,426.75
BUY
3 Nov 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
339,845
+69%
139,148
$4.92
$684,426.75
BUY
3 Nov 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
339,845
+69%
139,148
$4.92
$684,426.75
BUY
27 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
200,697
+62%
76,877
$4.86
$373,637.60
BUY
27 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
200,697
+62%
76,877
$4.86
$373,637.60
BUY
27 Oct 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
200,697
+62%
76,877
$4.86
$373,637.60
BUY
27 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
200,697
+62%
76,877
$4.86
$373,637.60
BUY
25 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
123,820
+100%
123,820
$4.81
$595,428.10
BUY
25 Oct 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
123,820
+100%
123,820
$4.81
$595,428.10
BUY
25 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
123,820
+100%
123,820
$4.81
$595,428.10
BUY
25 Oct 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
123,820
+100%
123,820
$4.81
$595,428.10
BUY
17 Oct 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
190,000
+216%
130,000
$3.56
$462,396.00
BUY
9 Jun 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,650,177
+59%
984,161
$13.50
$13,286,174.00
BUY
9 Jun 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,650,177
+59%
984,161
$13.50
$13,286,174.00
BUY
9 Jun 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,650,177
+59%
984,161
$13.50
$13,286,174.00
BUY
2 Jun 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,698,493
+2%
34,200
$13.03
$445,738.88
BUY
2 Jun 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,698,493
+2%
34,200
$13.03
$445,738.88
BUY
2 Jun 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,698,493
+2%
34,200
$13.03
$445,738.88
BUY
31 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,665,422
+10%
153,806
$13.46
$2,069,667.20
BUY
31 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,665,422
+10%
153,806
$13.46
$2,069,667.20
BUY
31 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,665,422
+10%
153,806
$13.46
$2,069,667.20
BUY
26 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,516,692
+1%
22,911
$13.49
$309,035.20
BUY
26 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,516,692
+1%
22,911
$13.49
$309,035.20
BUY
26 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,516,692
+1%
22,911
$13.49
$309,035.20
BUY
24 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,494,537
+4%
61,120
$13.42
$819,948.50
BUY
24 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,494,537
+4%
61,120
$13.42
$819,948.50
BUY
24 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,494,537
+4%
61,120
$13.42
$819,948.50
BUY
19 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,435,434
+2%
39,700
$13.36
$530,454.25
BUY
19 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,435,434
+2%
39,700
$13.36
$530,454.25
BUY
19 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,435,434
+2%
39,700
$13.36
$530,454.25
BUY
17 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,397,044
+12%
151,699
$13.33
$2,022,003.80
BUY
17 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,397,044
+12%
151,699
$13.33
$2,022,003.80
BUY
17 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,397,044
+12%
151,699
$13.33
$2,022,003.80
BUY
13 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,250,351
+14%
162,531
$2.63
$427,891.16
BUY
13 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,250,351
+14%
162,531
$2.63
$427,891.16
BUY
13 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,250,351
+14%
162,531
$2.63
$427,891.16
BUY
11 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,092,698
+17%
166,350
$11.43
$1,902,031.90
BUY
11 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,092,698
+17%
166,350
$11.43
$1,902,031.90
BUY
11 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,092,698
+17%
166,350
$11.43
$1,902,031.90
BUY
9 May 2022
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
932,323
+13%
114,440
$10.95
$1,252,982.40
BUY
9 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
932,323
+13%
114,440
$10.95
$1,252,982.40
BUY
9 May 2022
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
932,323
+13%
114,440
$10.95
$1,252,982.40
SELL
6 Dec 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
908,893
-3%
30,000
$18.40
$552,150.00
SELL
18 Nov 2021
WOODHOUSE DAVID J
Chief Executive Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
0
-100%
15,000
$20.02
$300,300.00
SELL
15 Nov 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
884,449
-3%
30,000
$19.72
$591,750.00
SELL
11 Oct 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
899,449
-3%
30,000
$20.28
$608,250.00
SELL
5 Oct 2021
Lieu Hsiao D
SVP, Chief Medical Officer, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
0
-100%
2,000
$22.00
$44,000.00
SELL
13 Sep 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
932,486
-3%
30,000
$25.84
$775,305.94
SELL
11 Aug 2021
Lieu Hsiao D
SVP, Chief Medical Officer, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
0
-100%
10,258
$23.39
$239,934.00
SELL
9 Aug 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
959,449
-3%
30,000
$23.81
$714,222.40
SELL
3 May 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
920,005
-2%
25,000
$27.62
$690,500.00
SELL
12 Apr 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
945,005
-2%
25,000
$24.65
$616,250.00
SELL
1 Mar 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
970,005
-2%
25,000
$26.66
$666,500.00
SELL
16 Feb 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
995,005
-2%
25,000
$28.75
$718,750.00
SELL
4 Jan 2021
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
870,375
-2%
25,000
$29.28
$732,116.30
SELL
14 Dec 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
908,879
-2%
25,000
$28.01
$700,275.94
SELL
2 Nov 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
920,005
-2%
25,000
$17.70
$442,500.03
SELL
12 Oct 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
945,005
-2%
25,000
$17.02
$425,500.00
BUY
1 Sep 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,827,025
+3%
64,089
$17.65
$1,131,357.80
BUY
1 Sep 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,827,025
+3%
64,089
$17.65
$1,131,357.80
SELL
1 Sep 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
977,618
-2%
25,000
$17.83
$445,829.12
BUY
27 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,762,936
+3%
62,494
$17.83
$1,114,381.80
BUY
27 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,762,936
+3%
62,494
$17.83
$1,114,381.80
BUY
21 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,700,442
+1%
18,445
$17.96
$331,349.38
BUY
21 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,700,442
+1%
18,445
$17.96
$331,349.38
BUY
13 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,681,997
+3%
64,313
$17.65
$1,135,362.40
BUY
13 Aug 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,681,997
+3%
64,313
$17.65
$1,135,362.40
SELL
10 Aug 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
995,005
-2%
25,000
$19.02
$475,500.00
BUY
30 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,617,684
+0%
732
$17.99
$13,168.68
BUY
30 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,617,684
+0%
732
$17.99
$13,168.68
BUY
28 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,616,952
+0%
4,105
$17.99
$73,848.95
BUY
28 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,616,952
+0%
4,105
$17.99
$73,848.95
BUY
24 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,612,847
+4%
72,583
$17.93
$1,301,643.20
BUY
24 Jul 2020
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,612,847
+4%
72,583
$17.93
$1,301,643.20
SELL
1 Jul 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
1,027,268
-2%
25,000
$18.91
$472,727.88
SELL
15 Jun 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
1,064,405
-2%
25,000
$21.65
$541,166.00
SELL
15 May 2020
Lieu Hsiao D
SVP, Chief Medical Officer, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
182
-89%
1,562
$22.00
$34,364.00
BUY
8 Apr 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,896,978
+0%
112,602
$14.95
$1,683,399.90
BUY
8 Apr 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,540,071
+7%
112,602
$14.95
$1,683,399.90
BUY
8 Apr 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,706,978
+0%
112,602
$14.95
$1,683,399.90
BUY
8 Apr 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,540,071
+7%
112,602
$14.95
$1,683,399.90
BUY
3 Apr 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,784,376
+0%
138,315
$14.17
$1,960,233.20
BUY
3 Apr 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,427,469
+10%
138,315
$14.17
$1,960,233.20
BUY
3 Apr 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,594,376
+0%
138,315
$14.17
$1,960,233.20
BUY
3 Apr 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,427,469
+10%
138,315
$14.17
$1,960,233.20
BUY
31 Mar 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,646,060
+1%
250,984
$12.40
$3,111,021.00
BUY
31 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,289,154
+24%
250,984
$12.40
$3,111,021.00
BUY
31 Mar 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,456,060
+1%
250,984
$12.40
$3,111,021.00
BUY
31 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,289,154
+24%
250,984
$12.40
$3,111,021.00
BUY
23 Mar 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,395,076
+1%
301,180
$11.89
$3,580,543.80
BUY
23 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,038,170
+40%
301,180
$11.89
$3,580,543.80
BUY
23 Mar 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,205,076
+1%
301,180
$11.89
$3,580,543.80
BUY
23 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,038,170
+40%
301,180
$11.89
$3,580,543.80
BUY
19 Mar 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
17,093,896
+1%
291,546
$11.68
$3,404,773.00
BUY
19 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
736,990
+65%
291,546
$11.68
$3,404,773.00
BUY
19 Mar 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,903,896
+1%
291,546
$11.68
$3,404,773.00
BUY
19 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
736,990
+65%
291,546
$11.68
$3,404,773.00
BUY
5 Mar 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,802,352
+0%
8,307
$18.00
$149,526.00
BUY
5 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
445,444
+1%
8,307
$18.00
$149,526.00
BUY
5 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
445,444
+1%
8,307
$18.00
$149,526.00
BUY
5 Mar 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,612,351
+0%
8,307
$18.00
$149,526.00
BUY
2 Mar 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,794,044
+0%
62,868
$17.97
$1,129,424.50
BUY
2 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
437,137
+16%
62,868
$17.97
$1,129,424.50
BUY
2 Mar 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
437,137
+16%
62,868
$17.97
$1,129,424.50
BUY
2 Mar 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,604,044
+0%
62,868
$17.97
$1,129,424.50
BUY
26 Feb 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,731,176
+0%
75,447
$17.91
$1,351,593.40
BUY
26 Feb 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
374,269
+25%
75,447
$17.91
$1,351,593.40
BUY
26 Feb 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
374,269
+25%
75,447
$17.91
$1,351,593.40
BUY
26 Feb 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,541,176
+0%
75,447
$17.91
$1,351,593.40
BUY
6 Feb 2020
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,655,729
+0%
44,900
$15.96
$716,604.00
BUY
6 Feb 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
298,822
+17%
44,900
$15.96
$716,604.00
BUY
6 Feb 2020
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
298,822
+17%
44,900
$15.96
$716,604.00
BUY
6 Feb 2020
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,465,729
+0%
44,900
$15.96
$716,604.00
SELL
7 Jan 2020
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
1,068,443
-4%
50,765
$18.04
$915,772.56
BUY
11 Nov 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,610,829
+0%
15
$12.00
$180.00
BUY
11 Nov 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
253,922
+0%
15
$12.00
$180.00
BUY
11 Nov 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,420,829
+0%
15
$12.00
$180.00
BUY
11 Nov 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
253,922
+0%
15
$12.00
$180.00
BUY
4 Nov 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,610,814
+0%
8,409
$11.99
$100,823.91
BUY
4 Nov 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
253,907
+3%
8,409
$11.99
$100,823.91
BUY
4 Nov 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,420,814
+0%
8,409
$11.99
$100,823.91
BUY
4 Nov 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
253,907
+3%
8,409
$11.99
$100,823.91
SELL
31 Oct 2019
CHEN JIN-LONG
Chief Scientific Officer, Director, Officer
NGM BIOPHARMACEUTICALS INC
(NGM)
996,693
-4%
50,765
$12.90
$654,782.56
BUY
22 Oct 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,602,405
+0%
4,387
$11.93
$52,351.82
BUY
22 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
245,498
+1%
4,387
$11.93
$52,351.82
BUY
22 Oct 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,412,405
+0%
4,387
$11.93
$52,351.82
BUY
22 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
245,498
+1%
4,387
$11.93
$52,351.82
BUY
17 Oct 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,598,018
+0%
84,939
$11.57
$982,603.25
BUY
17 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
241,111
+54%
84,939
$11.57
$982,603.25
BUY
17 Oct 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,408,018
+0%
84,939
$11.57
$982,603.25
BUY
17 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
241,111
+54%
84,939
$11.57
$982,603.25
BUY
14 Oct 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,513,079
+0%
103,000
$10.31
$1,061,930.00
BUY
14 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
156,172
+193%
103,000
$10.31
$1,061,930.00
BUY
14 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
156,172
+193%
103,000
$10.31
$1,061,930.00
BUY
14 Oct 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,323,079
+0%
103,000
$10.31
$1,061,930.00
BUY
9 Oct 2019
GOEDDEL DAVID V
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,410,079
+0%
53,172
$10.44
$555,292.94
BUY
9 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
53,172
+100%
53,172
$10.44
$555,292.94
BUY
9 Oct 2019
Svennilson Peter
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,220,079
+0%
53,172
$10.44
$555,292.94
BUY
9 Oct 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
53,172
+100%
53,172
$10.44
$555,292.94
BUY
7 Aug 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,356,907
+1%
224,664
$14.00
$3,145,294.20
BUY
7 Aug 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,597,816
+9%
224,664
$14.00
$3,145,294.20
BUY
7 Aug 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,166,907
+1%
224,664
$14.00
$3,145,294.20
BUY
5 Aug 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,132,243
+0%
6,134
$13.98
$85,727.32
BUY
5 Aug 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,373,152
+0%
6,134
$13.98
$85,727.32
BUY
5 Aug 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,942,243
+0%
6,134
$13.98
$85,727.32
BUY
1 Aug 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,126,109
+0%
4,382
$13.98
$61,244.20
BUY
1 Aug 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,367,018
+0%
4,382
$13.98
$61,244.20
BUY
1 Aug 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,936,109
+0%
4,382
$13.98
$61,244.20
BUY
29 Jul 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,121,727
+0%
28,056
$13.68
$383,921.75
BUY
29 Jul 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,362,636
+1%
28,056
$13.68
$383,921.75
BUY
29 Jul 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,931,727
+0%
28,056
$13.68
$383,921.75
BUY
24 Jul 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,093,671
+0%
89,866
$13.49
$1,212,429.90
BUY
24 Jul 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,334,580
+4%
89,866
$13.49
$1,212,429.90
BUY
24 Jul 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,903,671
+0%
89,866
$13.49
$1,212,429.90
BUY
19 Jul 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
16,003,805
+0%
67,742
$13.49
$913,914.50
BUY
19 Jul 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,244,714
+3%
67,742
$13.49
$913,914.50
BUY
19 Jul 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,813,805
+0%
67,742
$13.49
$913,914.50
BUY
15 Jul 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,936,063
+0%
20,088
$13.72
$275,602.50
BUY
15 Jul 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,915,975
+0%
31,884
$13.88
$442,516.38
BUY
15 Jul 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,176,972
+0%
20,088
$13.72
$275,602.50
BUY
15 Jul 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,746,063
+0%
20,088
$13.72
$275,602.50
BUY
11 Jul 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,156,884
+1%
31,884
$13.88
$442,516.38
BUY
11 Jul 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,725,975
+0%
31,884
$13.88
$442,516.38
BUY
24 Jun 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,884,091
+0%
12,240
$13.78
$168,650.06
BUY
24 Jun 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,125,000
+0%
12,240
$13.78
$168,650.06
BUY
24 Jun 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,694,091
+0%
12,240
$13.78
$168,650.06
BUY
19 Jun 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,871,851
+0%
34,377
$13.90
$477,848.62
BUY
19 Jun 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,112,760
+1%
34,377
$13.90
$477,848.62
BUY
19 Jun 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,681,851
+0%
34,377
$13.90
$477,848.62
BUY
12 Jun 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,837,474
+0%
29,760
$14.05
$418,183.72
BUY
12 Jun 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,078,383
+1%
29,760
$14.05
$418,183.72
BUY
12 Jun 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,647,474
+0%
29,760
$14.05
$418,183.72
BUY
7 Jun 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,807,714
+0%
23,500
$13.74
$322,894.06
BUY
7 Jun 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,048,623
+1%
23,500
$13.74
$322,894.06
BUY
7 Jun 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,617,714
+0%
23,500
$13.74
$322,894.06
BUY
4 Jun 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,784,214
+0%
25,200
$13.40
$337,648.50
BUY
4 Jun 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
2,025,123
+1%
25,200
$13.40
$337,648.50
BUY
4 Jun 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,594,214
+0%
25,200
$13.40
$337,648.50
BUY
20 May 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,759,014
+0%
50,000
$13.50
$675,000.00
BUY
20 May 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,999,923
+2%
50,000
$13.50
$675,000.00
BUY
20 May 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,569,014
+0%
50,000
$13.50
$675,000.00
BUY
15 May 2019
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,540,264
+0%
193
$18.00
$3,474.00
BUY
15 May 2019
COLUMN GROUP L P
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,540,264
+0%
193
$18.00
$3,474.00
BUY
10 May 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,709,014
+0%
17,923
$13.85
$248,233.56
BUY
10 May 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,949,923
+0%
17,923
$13.85
$248,233.56
BUY
10 May 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,519,014
+0%
17,923
$13.85
$248,233.56
BUY
7 May 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,691,091
+0%
57,000
$14.10
$803,700.00
BUY
7 May 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,932,000
+3%
57,000
$14.10
$803,700.00
BUY
7 May 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,501,091
+0%
57,000
$14.10
$803,700.00
BUY
8 Apr 2019
GOEDDEL DAVID V
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
15,634,091
+13%
1,875,000
$16.00
$30,000,000.00
BUY
8 Apr 2019
COLUMN GROUP L P
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
1,875,000
+12600%
1,890,000
$16.00
$30,240,000.00
BUY
8 Apr 2019
Svennilson Peter
Director, 10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
20,000
+101%
1,895,000
$16.00
$30,320,000.00
BUY
8 Apr 2019
Hooper Suzanne Sawochka
Director
NGM BIOPHARMACEUTICALS INC
(NGM)
7,000
+100%
7,000
$16.00
$112,000.00
BUY
8 Apr 2019
Merck & Co., Inc.
10% Owner
NGM BIOPHARMACEUTICALS INC
(NGM)
12,955,016
+46%
4,121,683
$16.00
$65,946,930.00
Home